Finzati - Logo
CC logo

The Chemours Company

CC • Chemicals - Specialty
$0.00
— 0.00 (0.00%)
EarningsLatest report: Mar 31, 2026
HIGHER-RISK PROFILECautionConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$3.18B
Growth
-0.9%
Cash Flow
4/5
Trend
Mostly stable
Evidence
Positive free cash flow · 0.34Consistent free cash flow · 4/5Healthy liquidity · 1.78High debt level · 18.34Negative growth trend
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: May 5, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:36 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$0.00
Change0.00%
Market Cap$3.18B
52W Range10.44 - 28.67
Beta1.39
Gross Margin15.53%
Oper. Margin-0.09%
Profit Margin-6.65%
Debt/Eq18.34
Current Ratio1.78
Quick Ratio0.85
Revenue 5Y-0.92%

Investment DNA

How strong this company looks for long-term investors

41
out of 100
Business Quality
Margins, moat, returns
27/100
Financial Strength
Debt, cash, stability
45/100
Growth Potential
Revenue and expansion
21/100
Price Attractiveness
Cheap or expensive today
60/100
Why this score▼
Positive free cash flow · 0.34Consistent free cash flow · 4/5Healthy liquidity · 1.78High debt level · 18.34Negative growth trendWeak profitability

Analyst view

Analyst sentiment and price target

Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-06-25
Low
$17.00
Mean
$25.75
Median
$29.50
High
$30.00

Company Overview

IPO: 6/19/2015
Industry: Chemicals - Specialty
P/B i: 7.09
Debt / Equity i: 18.34
Operating Margin: -0.09%
Net Margin: -6.65%
ROE i: -
ROIC: -

Financial Health

Score9 / 20
Debt / Equity: 18.34
Current Ratio: 1.78
Quick Ratio: 0.85
Status: Moderate

Warnings

  • High debt level

Insider Transactions

Recent executive and insider activity

Brokaw George R
Transaction: 05/06/2026
BUY
Change
+7,182
Price
Not reported
Filing
05/08/2026
Type
BUY
Kava Joseph Daniel
Transaction: 05/06/2026
BUY
Change
+7,182
Price
Not reported
Filing
05/08/2026
Type
BUY
Keohane Sean D
Transaction: 05/06/2026
BUY
Change
+7,182
Price
Not reported
Filing
05/08/2026
Type
BUY